Revolutionize Your Omics Experiments
![](https://cdn.prod.website-files.com/627badd0d06f4dfa4f929764/665d70b62e84a43baa90879a_image%20220.webp)
High-throughput omics experiments, such as NGS and RNA-Seq, are essential for discovering biological targets linked to diseases.
However, these experiments are not only costly but also time-intensive, often requiring extensive literature reviews to identify potential gene targets.
Traditional methods of target identification are slow and can lead to missed opportunities in drug development.
Gene Inspector leverages Generative AI and advanced PubMed APIs to revolutionize the target identification process.
This solution provides rapid, data-driven insights into gene targets, transforming how researchers approach omics experiments.
Gene Inspector is our GenAI-enabled Research Intelligence platform, which allows scientists to perform efficient literature review of potential gene candidates in minutes. It generates insights based on context-rich information digested from multiple scientific publications. Scientists can get insights into up to 100 genes in one shot and gain valuable data from omics experiments.
Gene Inspector is valuable for evaluating results produced from genomics (eg: Next Generation Sequencing), transcriptomics (eg: RNA-Seq experiments) and proteomics studies like LC-MS (Liquid Chromatography-Mass Spectrometry).
Gene Inspector leverages Generative AI technologies to generate summarized information on potential gene biomarkers like biological expression, role in disease pathophysiology, prediction of response to clinical interventions and many more. Utilizing the prioritization feature, scientists can streamline biomarker discovery process and foster development of novel diagnostic modalities.
Identification of a promising target that is ‘druggable’ and relevant to the disease is a herculean task. Gene Inspector provides a comprehensive overview of prospective biological targets with information on therapeutic relevance to disease phenotype, biological expression, druggability profiles, etc. using data digested from scientific publications. This approach delivers rich context to omics experiment results and guides scientists to choose the right target with the desired effect.
Gene Inspector generates summaries based on the top relevant scientific publications indexed in the PubMed database.